Skip to main content
. 2018 Mar 14;52(5):1443–1454. doi: 10.3892/ijo.2018.4316

Figure 6.

Figure 6

EPB41L3 expression predicts overall survival in patients with ESCC. Kaplan-Meier analysis with the log-rank test was used to assess the association between levels of tumor EPB41L3 expression and patients' survival time. EPB41L3, erythrocyte membrane protein band 4.1 like 3; ESCC, esophageal squamous cell carcinoma.